BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Saturday, March 1, 2025
Home
»
Authors
»
Jim Stommen
Articles by Jim Stommen
'Second-tier' firms seen with a growing role as acquirers
May 26, 2005
By
Jim Stommen
No Comments
Some clouds seen in sunny investing climate for sector
May 19, 2005
By
Jim Stommen
No Comments
Choice of regulatory paths, relationship-building are key
May 17, 2005
By
Jim Stommen
No Comments
‘Second-tier’ firms seen having a growing role as acquirers
May 16, 2005
By
Jim Stommen
No Comments
By whatever name, taking some services outside seen growing
May 13, 2005
By
Jim Stommen
No Comments
To attract partners and make alliances work, do homework
May 13, 2005
By
Jim Stommen
No Comments
Some clouds seen in sunny investing climate for devices
May 12, 2005
By
Jim Stommen
No Comments
Gathering puts big spotlight on Upper Midwest device sector
May 11, 2005
By
Jim Stommen
No Comments
Split Rock raises $275M for first fund; Canaan adds $450M
May 5, 2005
By
Jim Stommen
No Comments
Growth of med-tech sector is a boon to Ireland's economy
May 1, 2005
By
Jim Stommen
No Comments
Previous
1
2
…
24
25
26
27
28
29
30
31
32
Next